New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting highlights a ...
A stem cell therapy designed to repair damaged nerve pathways is moving closer to clinical testing for people with chronic spinal cord injury, according to a July 13 Inside Precision Medicine report ...
Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three years and no effective treatments. In ALS, motor neurons in the spinal cord, ...
A phase 1 clinical trial demonstrated the long-term safety and feasibility of neural stem cell transplantation for treating chronic spinal cord injuries. The corresponding study was published in Cell ...
A phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and feasibility of neural stem cell transplantation for ...
Spinal cord injuries can have devastating consequences for those affected. Nerve cells in the spinal cord rarely regenerate naturally, while scarring often prevents the regrowth of nerve fibers.
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological ...
Using neural stem cells could help treat spinal injuries once thought to be untreatable -- a new phase 1 trial has determined this approach is safe. A Phase I clinical trial led by researchers at ...
Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three years and no effective treatments. In ALS, motor neurons in the spinal cord, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results